- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Infinitt, Intelerad Top KLAS List of PACS Innovators
Infinitt and Intelerad rose to the top among PACS vendors who offer timely upgrades and expanded usability, according to a KLAS report released at RSNA 2012.
CHICAGO - Infinitt and Intelerad rose to the top among PACS vendors who offer timely upgrades and expanded usability, according to a KLAS report.
As demand for PACS has grown, so has the need for vendors to differentiate themselves, according to the report which shares customer feedback. Other top-rated vendors endorsed by their customers include DR Systems, McKesson, Novarad, and Sectra, according to KLAS.
"The top-rated PACS innovators have a track record of improvement," Ben Brown, report author and KLAS research director, said in a statement. "The vendors that land in the middle tier of this study offer solid technology and innovation, but at a slower pace. Vendors in that group are meeting most of providers' expectations, but they are not exceeding them like the top-tier vendors are."
Middle-tier vendors are Carestream, Fuji, Merge, and Philips, according to KLAS. Vendor success in meeting customer’s needs varies among these vendors. Although Fuji and Carestream are reputable global PACS vendors, customers reported wanting greater development. Philips is playing catch-up, and Merge's development speed has been impacted by their focus on consolidating their PACS portfolio, according to KLAS.
Some vendors are falling behind when it comes to development and functionality, including Agfa, Cerner, GE, and Siemens, which KLAS said fall in the bottom tier of PACS innovators. However, the vendors in this group offer some stability and integration. Cerner and Siemens customers cited lack of functionality, which has not been completely solved with upgrades, and Agfa and GE customers noted their solutions are scalable and stable, but upgrades are not keeping pace with the innovation.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
